Why Some PureLift Users Don't See Results — And How to Fix It

About the Authors

Bertica M. Rubio, M.D.

Bertica M. Rubio, M.D.

Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School

Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.

With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.

Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.

Andrew Conrad Barile, PT, DPT

Andrew Conrad Barile, PT, DPT

Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)

Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.

Daniel Grinberg, MD, FACS

Daniel Grinberg, MD, FACS

Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine

Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.

Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.

Prof. Dr. med. Ivo Buschmann

Prof. Dr. med. Ivo Buschmann

Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin

Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.

Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.

Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.

The most uncomfortable article in any device-brand's content library is the one that addresses the users who aren't seeing the results they expected. Most brands avoid it. We don't think that's the right move. The honest truth is that some PureLift users don't see the change they hoped for in the first 8–12 weeks — and almost always, the reason is identifiable, fixable, and worth talking about openly.

This article walks through the seven most common reasons for disappointing PureLift results, in honest order of frequency, with the specific fix for each. If you're reading this because you have been using PureLift consistently and aren't seeing what you hoped for, the diagnostic framework below will almost certainly identify the issue.

The seven reasons, in honest order of frequency

1. You stopped before the structural change had time to surface

This is by far the most common reason. Users evaluate at 3–4 weeks, don't see dramatic visible change, and reduce or stop their routine. The published facial NMES clinical trials — Kavanagh 2012, Omatsu 2024 — document statistically significant outcomes at 6 weeks and beyond, with 12-week endpoints being the consistent measurement standard. The literature does not show 4-week visible structural changes in resting baseline.

The fix: recommit to 12 weeks of consistent use. Take a neutral photo today. Compare at week 12, not at week 4. The structural muscle adaptation that produces visible change is happening underneath; you just can't see it yet. See our First 30 Days With PureLift guide for the week-by-week expectations.

2. You're not using the Activator Serum (or you're using a different gel)

The Activator Serum is not optional packaging. It is the conductive layer engineered to drop surface skin impedance so the EMS waveform reaches the muscle layer where the work happens. Running PureLift on dry skin or on incompatible gels (oil-based, glycerin-heavy, or formulations not engineered for conductivity) reduces session effectiveness substantially.

The fix: use the Activator Serum every session. If you have been using a different gel or no medium at all, switching alone can produce a noticeable improvement within 2–3 sessions. The session feels different too — smoother glide, more even contact, less surface tingling.

3. You're using it inconsistently — too few sessions, or burst-and-pause patterns

The clinical evidence on muscle adaptation is consistent: sustained, regular stimulation produces structural change. Burst patterns (5 sessions in one week, then 2 weeks off, then 5 more sessions) produce less cumulative benefit than steady cadence (3 sessions per week, every week).

The fix: aim for 3–5 sessions per week, evenly distributed. Schedule them in advance if needed. Treat skipping a week as treating skipping a gym week — easy to do, but it slows progress. See The Smart-Delivery Dose Question for the dose-response curve.

4. You're running at intensity that's too low to engage muscle

Some users — particularly first-time EMS users — start at level 2 or 3, feel the sensation, and assume they have reached a meaningful intensity. The published evidence is clear that high-intensity stimulation outperforms low-intensity stimulation for muscle force outcomes (Snyder-Mackler et al., 1995, J Bone Joint Surg Am, PMID 7642660).

Running at sub-threshold intensity produces sensation but not contraction. You feel the tingle, but the muscle isn't engaging.

The fix: increase intensity gradually until you see visible muscle contraction. The cheek apple should clearly lift during the session. The jaw line should pull during platysmal-area treatment. If you cannot see contraction, the intensity is too low. Build up over 2–3 weeks until you are operating at a level that produces visible engagement without crossing into discomfort.

5. Your skin barrier or hydration is compromised

If your skin barrier is impaired — from over-exfoliation, aggressive actives, climate change, hormonal shift, or a recent retinoid escalation — EMS sessions feel more reactive than they should and produce more redness than usable engagement. The skin layer reacts before the muscle layer can fully respond.

The fix: pause active skincare for 2 weeks. Switch to a barrier-repair routine (ceramides, hyaluronic acid, gentle cleanser, no acids, no retinoids). Reintroduce PureLift at lower intensity after barrier function has visibly recovered. Most users see the difference within 10–14 days of barrier reset.

6. You're using PureLift on muscles that are also being chemically relaxed

If you have Botox in the same muscles you are trying to strengthen, the muscles cannot contract — the toxin is preventing acetylcholine release. EMS in a fully Botoxed muscle produces less visible engagement because the muscle is silenced. The work goes into untreated areas more effectively than into treated ones.

The fix: review your Botox treatment areas with your injector. Coordinate so that Botox addresses the muscles you want to relax (forehead, glabella, crow's feet) while EMS addresses the muscles you want to strengthen (cheek, jawline, neck). See our EMS + Botox guide for the complementary strategy.

7. Your expectations are calibrated to a different category of intervention

EMS is muscle conditioning. It is not a filler substitute. It is not a face lift. It produces structural muscle change over weeks to months, not volume restoration in the cellular-replacement sense.

If you are evaluating PureLift against the standard of "did my nasolabial fold disappear like it would after filler" or "did my jowls lift like they would after a facelift" — the answer is no, because that's the wrong measurement standard. EMS produces firmness, lift, and tone at the muscle layer. It does not replace volume that is gone, and it does not surgically reposition tissue.

The fix: recalibrate against the right measurement. Take a neutral photo at baseline. Take another at 8 weeks, and at 12 weeks. Look for: jawline definition, cheek lift, the resting tone of the lower face, the firmness of the upper neck. These are the EMS outcomes. If you also want volume restoration in specific regions, that's a filler conversation, not an EMS conversation — and the two are complementary, not competitive.

The diagnostic checklist

If you are not seeing results, work through these in order:

  1. Have you been using PureLift consistently for at least 12 weeks? If less, the answer is to keep going.
  2. Are you using the Activator Serum every session? If not, start using it and reassess in 4 weeks.
  3. Are you running at least 3 sessions per week, every week, without long gaps? If not, restart the cadence and reassess in 6 weeks.
  4. Are you running at intensity that produces visible muscle contraction during the session? If not, increase gradually over 2 weeks.
  5. Is your skin barrier healthy? If not, reset for 2 weeks before continuing.
  6. Are you running EMS on muscles that are also Botoxed? If yes, focus EMS on untreated areas.
  7. Are your expectations calibrated to filler or surgical outcomes rather than muscle conditioning outcomes? If yes, recalibrate.

Almost every "not seeing results" case we have encountered in customer support resolves to one or two items on this list. Address the right item, and the next 4–8 weeks of use almost always produce visible change.

When the answer might genuinely be "it didn't work for me"

For full intellectual honesty: there is always a small fraction of users for whom EMS does not produce the desired outcome even when used correctly. Individual response to electrical stimulation varies — some users respond more strongly, some less. The published clinical literature reflects this in standard deviations around the mean response.

If you have honestly worked through the seven-item checklist above and have used PureLift correctly and consistently for 16 weeks without seeing meaningful change, two possible reasons remain:

Individual variability in response. Some users have facial musculature that is already at high baseline tone, with less headroom for visible muscle thickening. Others have skin conditions or anatomical factors that limit how much visible change EMS can produce.

Different problem, different solution. If the primary issue is volume loss rather than muscle laxity, fillers will address it more directly than EMS. If the primary issue is skin surface texture or pigmentation, RF or LED will address it more directly. EMS is the right tool for muscle conditioning. It is not the right tool for every facial concern.

Our 30-day risk-free trial exists for exactly this reason. If PureLift is not the right tool for you, return it. The brand position is that the device should produce visible improvement when used correctly — and if it doesn't, the responsible action is to give the user their money back rather than to convince them that they're using it wrong.

The bottom line

The most common reasons PureLift users don't see results are identifiable, fixable, and worth talking about openly. Inconsistent use, too-low intensity, no Activator Serum, premature evaluation — these are the issues that produce the "didn't work" perception. Address them, give the routine 12 weeks, and almost all users see the structural muscle adaptation the clinical evidence documents.

For the full evidence base, see the references hub. For the 12-month outcome curve, see Facial EMS Across 12 Months. For the 30-day expectations, see The First 30 Days With PureLift.

If you've worked through the diagnostic and still aren't seeing change at week 16, PureLift's 30-day trial and replacement-or-return support is the right next step. We mean it.

References: Kavanagh S et al. (2012), J Cosmet Dermatol 11(4):261-266, PMID 23174048. Omatsu J et al. (2024), J Cosmet Dermatol 23(10):3222-3233, PMID 38992992. Snyder-Mackler L et al. (1995), J Bone Joint Surg Am 77(8):1166-1173, PMID 7642660.

Back to blog